Susan Stormzand-Murphy
Internal Medicine · Franklin, INNPI 1417992660
Payments from drug & device makers
Across 115 payments — averaging $18.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$356
- GSK$329
- Novo Nordisk$315
- Boehringer Ingelheim$167
- Biohaven Pharmaceutical Holding Company Ltd.$155
- Abbott$121
- plus $630 from 20 others
What the payments were for
- Food & beverage$2,073100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 20 | $356 |
| GSK | 8 | $329 |
| Novo Nordisk | 34 | $315 |
| Boehringer Ingelheim | 7 | $167 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $155 |
| Abbott | 6 | $121 |
| Axonics, Inc. | 1 | $72 |
| Merck | 4 | $63 |
| Pfizer | 5 | $63 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $55 |
| AstraZeneca | 3 | $43 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $41 |
| Novartis | 2 | $37 |
| Exact Sciences | 2 | $35 |
| Sanofi-aventis U.S. LLC | 2 | $31 |
| Idorsia Pharmaceuticals US Inc | 2 | $29 |
| Amarin Pharma, Inc. | 2 | $28 |
| Amgen | 1 | $23 |
| Sanofi Pasteur Inc. | 1 | $16 |
| IBSA Pharma Inc. | 1 | $16 |
| Medtronic | 1 | $14 |
| Antares Pharma, Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
| Endo Pharmaceuticals Inc. | 1 | $13 |
| Ultragenyx Pharmaceutical Inc. | 1 | $12 |
| Lilly USA, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$125
- TRELEGY ELLIPTA$125
- AREXVY$110
How this compares
$2,073 in reported general payments places this provider in the 80th percentile of 1,747 internal medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SynthroidLevothyroxine Sodium | 30 | $2,270 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $1,897 |
| LevoxylLevothyroxine Sodium | 43 | $1,818 |
| Atorvastatin Calcium | 77 | $597 |
| Amlodipine Besylate | 69 | $450 |
| Metoprolol Succinate | 33 | $417 |
| Metformin Hcl | 23 | $387 |
| Tamsulosin Hcl | 13 | $338 |
| Pravastatin Sodium | 30 | $330 |
| Metformin Hcl ErMetformin Hcl | 20 | $310 |
| Lisinopril | 50 | $288 |
| Omeprazole | 22 | $282 |
| Simvastatin | 43 | $277 |
| Glimepiride | 20 | $273 |
| Losartan Potassium | 33 | $271 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieSynthroid | $356 | $2,27030 claims |
| PfizerLevoxyl | $63 | $1,81843 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,747 internal medicine providers in Indiana.
Other internal medicine in Franklin
- George CornettFranklin$1.3M
- Robert BuynakValparaiso$24.2M
- Mohammed AllawNewburgh$3.6M
- Raj VuppalanchiIndianapolis$3.4M
- Phillip TothIndianapolis$3.2M
- Ajita NarayanLafayette$951K
- Abhinav SinghGreenwood$738K
- Georgiann LinnemeierIndianapolis$692K
- Wa'el BakdashAnderson$625K
- Rita SchmidSouth Bend$599K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.